Choksi Laboratories Ltd (CHOKSILA) is currently trading at 117.95 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Choksi Laboratories Limited specializes in contract testing and analytical services, offering a wide range of consulting and laboratory solutions to various industries. The company supports over 1000 product analyses and continually expands its service offerings. This vast range reflects a robust capability to cater to diverse industrial needs. Renowned for its expertise, CLL provides precise calibration services aligned with national and international standards, vital for quality management and reducing defects. Strategically located laboratories across India, including facilities in Gujarat, Chandigarh, Goa, and Bangalore, underline the company’s operational reach and expansion history. Strategic registrations and evolving collaborations reinforce its reputation as a partner in regulatory compliance and quality assurance across sectors including pharmaceuticals and food.

Over the past 52 weeks, Choksi Laboratories Ltd has traded between a low of ₹81.85 and a high of ₹236.70. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Choksi Laboratories Ltd has a market capitalization of approximately 80.90. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Choksi Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 41.07 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 80.90 Cr, Choksi Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Choksi Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Choksi Laboratories Ltd is 41.07. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.